US approves Pfizer vaccine for emergency use

The United States' Food and Drug Administration has given the go-ahead for urgent use of the company's vaccine “Pfixer” and “BioNTech” vs. Coronavirus. “Autoriisation of the Food and Drug Administration for emergency use of the first vaccine against Ovid-19 is an important step in combating this devastating pandemic that has affected [...]
“Autoriisation of the Food and Drug Administration for the urgent use of the first vaccine against Ovid-19 is an important step in combating this devastating pandemic that has affected so many families in the United States and around the world”, the institution's commissioner Dr said through a statement. Steppehn Hahn.
This decision marks a turning point in the United States, where over 294 thousand Americans have died from Coronervirus, more than in any other country in the world. The United States followed the examples of Great Britain, Canada, and Mexico, which have also approved the use of this vaccine for widespread public use.
In a video posted on social media, outgoing United States President Donald Trump appreciated Pfier's vaccine and named it one of the biggest scientific achievements in history, adding that the first doses will be distributed in less than 24 hours, says The Guardian, broadcast the Express.
Scientists are still doing research to find out how long the immune response of this vaccine lasts, the scale of cases without symptoms in people who are vaccinated and to confirm whether vaccine prevents the spread of the virus from vaccinated persons to others.
The vaccine in the United States will be allowed for people over the age of 16, while the company that has developed it is continuing a study of the effects of vaccine on children aged 12 to 15.












